Routine

Common variable immunodeficiency (CVID) — presentation & management

Antibody deficiency with recurrent infection and immune dysregulation · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

CVID is the commonest symptomatic primary antibody deficiency, presenting in adolescence or adulthood with recurrent sinopulmonary infections, low IgG with low IgA and/or IgM, and poor vaccine responses. Beyond infection it causes autoimmunity, granulomatous disease, enteropathy and increased lymphoma risk, and is treated with immunoglobulin replacement.

Red flags

  • Recurrent pneumonia with evolving bronchiectasis
  • Unexplained cytopenias (autoimmune haemolysis/thrombocytopenia)
  • Persistent lymphadenopathy or splenomegaly (lymphoma risk)
  • Chronic diarrhoea and weight loss (enteropathy)
  • Granulomatous lung or liver disease

Assessment

Differential diagnosis

  • Secondary hypogammaglobulinaemia (drugs, protein loss, malignancy)
  • Specific antibody deficiency with normal immunoglobulins
  • Selective IgA deficiency
  • X-linked agammaglobulinaemia (earlier onset, absent B cells)
  • Good syndrome (thymoma with immunodeficiency)

Investigations

  • Serum immunoglobulins (low IgG with low IgA and/or IgM)
  • Vaccine response testing (protein and polysaccharide antigens)
  • Lymphocyte subsets (B-cell numbers, switched memory B cells)
  • Exclude secondary causes (protein loss, drugs, myeloma, HIV)
  • CT chest for bronchiectasis and imaging for lymphoproliferation/granuloma

Management

  • Suspect CVID in recurrent sinopulmonary infections with low immunoglobulins beyond infancy
  • Confirm low IgG with low IgA/IgM and impaired vaccine responses
  • Exclude secondary causes of hypogammaglobulinaemia
  • Treat acute infections promptly with appropriate antibiotics and seek atypical organisms
  • Start immunoglobulin replacement to achieve a protective trough IgG level
  • Screen for and manage complications: bronchiectasis, autoimmune cytopenias, enteropathy, granulomatous disease
  • Avoid live vaccines and ensure household contacts are vaccinated
  • Manage long term in a specialist immunology centre with surveillance for lymphoma

Drugs & doses

Immunoglobulin replacement — IVIG 0.4-0.6 g/kg every 3-4 weeks, or subcutaneous equivalent weekly, titrated to trough IgG
Co-amoxiclav — 625 mg orally three times daily for acute bacterial infection
Prophylactic azithromycin — 250 mg orally three times weekly in selected patients with bronchiectasis
Prednisolone — 1 mg/kg orally for immune-mediated complications (specialist use)

Disposition

Manage in a specialist immunology service with immunoglobulin replacement and complication surveillance; admit severe acute infections.

Complications & pitfalls

  • Bronchiectasis and chronic lung disease
  • Autoimmune cytopenias and other autoimmunity
  • Granulomatous-lymphocytic interstitial lung disease
  • Enteropathy and malabsorption
  • Increased lymphoma and gastric cancer risk

Exam pearls

  • Diagnose only after excluding secondary causes of low immunoglobulins
  • CVID is about immune dysregulation as much as infection — screen for autoimmunity and malignancy
  • Immunoglobulin replacement is titrated to a protective trough and to clinical infection control
  • Avoid live vaccines and vaccinate close contacts

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.